Primer: genome editing with engineered nucleases

  title={Primer: genome editing with engineered nucleases},
  author={Natalie de Souza},
  journal={Nature Methods},
A brief description of tools for targeted cleavage and tailored modification of genomes is presented. 

Gene editing for cell engineering: trends and applications

A recent study on “multiplexed” gene editing revolutionized the knock-out and knock-in events of yeast and CHO, mammalian cells genome for metabolic engineering as well as high, stable, and consistent expression of a transgene encoding complex therapeutic protein such as monoclonal antibody.

The Regulatory Status of Genome‐edited Crops

Genome editing with engineered nucleases (GEEN) represents a highly specific and efficient tool for crop improvement with the potential to rapidly generate useful novel phenotypes/traits that do not readily fit current definitions of genetically engineered or genetically modified used within most regulatory regimes.

Genome Editing in Cancer Research and Cure

Current applications of cancer research and cure, and the possibility of genome editing being the possible cause of enhancing the risk of cancer development, are discussed in this chapter.

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome

Either TALEN or the CRISPR/Cas9 system could efficiently mediate in vivo replacement of DNA fragments of up to 5 kb in Drosophila, providing an ideal genetic tool for functional annotations of the Dosophila genome.

Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review

This review deciphers the use of RNAi, ribozyme engineering, CRISPR-Cas-based techniques for better strategies for antibody production.

Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine.

An overall view on essential elements in CRISPR/Cas systems and the nanoparticle-based delivery carriers including advantages and challenges is presented.

Status and Contribution of CRISPR/Cas9 Based Gene-Editing System in the Development of a Low-Immunogenic Wheat Variety

CRISPR/Cas9 technology could be a breakthrough in providing an alternative treatment for celiac disease, however, further studies are required to efficiently apply this gene-editing technology to develop a celiac-safe wheat variety.

CRISPR/Cas9-based Antibody Production in Plants

This review encompasses the applications of CRISPR technology for producing plant-based antibodies as well as transient expression system used due to the safe and improve the quality and quantity of antibody production.

Efficient TALEN construction and evaluation methods for human cell and animal applications

Transcription activator–like effector nucleases (TALENs) have recently arisen as effective tools for targeted genome engineering. Here, we report streamlined methods for the construction and


Zinc-finger nucleases transition to the CoDA

Potent and easily produced custom zinc-finger nucleases will be game-changers for the field, at a time when the field itself is changing.